Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reifenberger

Showing results (401-410 of 562) with videos related to

Pageof 57
Sort By:
Cancer Research|February 7, 2007
Distinct genetic signatures among pilocytic astrocytomas relate to their brain region originMukesh K Sharma, David B Mansur, Guido Reifenberger, et al.
International Journal of Cancer|March 12, 2014
Assessment and prognostic significance of the epidermal growth factor receptor vIII mutation in glioblastoma patients treated with concurrent and adjuvant temozolomide radiochemotherapyMichael Weller, Kerstin Kaulich, Bettina Hentschel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2006
Phase II trial of lomustine plus temozolomide chemotherapy in addition to radiotherapy in newly diagnosed glioblastoma: UKT-03Ulrich Herrlinger, Johannes Rieger, Dorothee Koch, et al.
Cancer Research|March 18, 2010
Tumor stroma-derived Wnt5a induces differentiation of basal cell carcinoma of Ptch-mutant mice via CaMKIIFrauke Nitzki, Arne Zibat, Simone König, et al.
Oncogene|October 31, 2012
miRNA-145 is downregulated in atypical and anaplastic meningiomas and negatively regulates motility and proliferation of meningioma cellsN Kliese, P Gobrecht, D Pachow, et al.
Journal of Neuro-Oncology|November 17, 2023
The long non-coding RNA OTX2-AS1 promotes tumor growth and predicts response to BCL-2 inhibition in medulloblastomaNan Qin, Eunice Paisana, Daniel Picard, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|February 18, 2011
Association of stem cell-related markers and survival in astrocytic gliomasFeng Wan, Christel Herold-Mende, Benito Campos, et al.
Neurology|March 17, 2017
Limited role for extended maintenance temozolomide for newly diagnosed glioblastomaDorothee Gramatzki, Philipp Kickingereder, Bettina Hentschel, et al.
Annals of Neurology|June 29, 2011
NOA-05 phase 2 trial of procarbazine and lomustine therapy in gliomatosis cerebriMartin Glas, Oliver Bähr, Jörg Felsberg, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 20, 2024
Gene expression profiling in porocarcinoma indicates heterogeneous tumor development and substantiates poromas as precursor lesionsSvenja Holst, Anna K Weber, Friedegund Meier, et al.
Pageof 57

Showing results (401-410 of 562) with videos related to

Sort By:
Pageof 57
Cancer Research|February 7, 2007
Distinct genetic signatures among pilocytic astrocytomas relate to their brain region originMukesh K Sharma, David B Mansur, Guido Reifenberger, et al.
International Journal of Cancer|March 12, 2014
Assessment and prognostic significance of the epidermal growth factor receptor vIII mutation in glioblastoma patients treated with concurrent and adjuvant temozolomide radiochemotherapyMichael Weller, Kerstin Kaulich, Bettina Hentschel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2006
Phase II trial of lomustine plus temozolomide chemotherapy in addition to radiotherapy in newly diagnosed glioblastoma: UKT-03Ulrich Herrlinger, Johannes Rieger, Dorothee Koch, et al.
Cancer Research|March 18, 2010
Tumor stroma-derived Wnt5a induces differentiation of basal cell carcinoma of Ptch-mutant mice via CaMKIIFrauke Nitzki, Arne Zibat, Simone König, et al.
Oncogene|October 31, 2012
miRNA-145 is downregulated in atypical and anaplastic meningiomas and negatively regulates motility and proliferation of meningioma cellsN Kliese, P Gobrecht, D Pachow, et al.
Journal of Neuro-Oncology|November 17, 2023
The long non-coding RNA OTX2-AS1 promotes tumor growth and predicts response to BCL-2 inhibition in medulloblastomaNan Qin, Eunice Paisana, Daniel Picard, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|February 18, 2011
Association of stem cell-related markers and survival in astrocytic gliomasFeng Wan, Christel Herold-Mende, Benito Campos, et al.
Neurology|March 17, 2017
Limited role for extended maintenance temozolomide for newly diagnosed glioblastomaDorothee Gramatzki, Philipp Kickingereder, Bettina Hentschel, et al.
Annals of Neurology|June 29, 2011
NOA-05 phase 2 trial of procarbazine and lomustine therapy in gliomatosis cerebriMartin Glas, Oliver Bähr, Jörg Felsberg, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 20, 2024
Gene expression profiling in porocarcinoma indicates heterogeneous tumor development and substantiates poromas as precursor lesionsSvenja Holst, Anna K Weber, Friedegund Meier, et al.
Pageof 57